Nilutamide
Showing 1 - 21 of 21
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)
Recruiting
- Prostate Cancer
- +4 more
- PET-directed Local Therapy using Surgery
- +10 more
-
Long Beach, California
- +15 more
Jul 29, 2022
Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Canada, Puerto
Active, not recruiting
- Stage I Prostate Adenocarcinoma
- +2 more
- Bicalutamide
- +7 more
-
Mobile, Alabama
- +313 more
Sep 7, 2022
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone
- +14 more
-
Gilbert, Arizona
- +301 more
Nov 8, 2021
Prostate Cancer Trial in Houston (Bicalutamide, Doxorubicin HCl, Estramustine Phosphate Sodium)
Completed
- Prostate Cancer
- Bicalutamide
- +8 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Oct 30, 2018
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Sydney, Melbourne (Olaparib, 177Lu-PSMA)
Recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Olaparib
- 177Lu-PSMA
-
Sydney, New South Wales, Australia
- +1 more
Jun 12, 2020
Prostate Carcinoma Metastatic to the Bone, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide)
Completed
- Prostate Carcinoma Metastatic to the Bone
- Castration Resistant Prostate Cancer
-
Detroit, Michigan
- +4 more
Apr 20, 2020
Prostate Cancer Trial in Bethesda, New Brunswick, Philadelphia (Sargramostim (GM-CSF, Leukine), Flutamide (Eulexin), PROSTVAC-F/
Completed
- Prostate Cancer
- Sargramostim (GM-CSF, Leukine)
- +3 more
-
Bethesda, Maryland
- +2 more
Nov 27, 2018
Prostatic Tumors Trial run by the NCI (Cabozantinib, Docetaxel, Prednisone)
Completed
- Prostatic Neoplasms
- Cabozantinib
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2019
Prostate Cancer Trial run by the NCI (aldesleukin, recombinant fowlpox-prostate specific antigen vaccine, recombinant vaccinia
Completed
- Prostate Cancer
- aldesleukin
- +5 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 28, 2015
Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)
Completed
- Atrial Fibrillation
- Marevan®
- +2 more
-
São Paulo, BrazilHospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016
Prostate Cancer Trial in Durham, Portland, Seattle (Nilutamide, Dasatinib)
An Alternative to A Fixed Schedule In Management Of Prostate
Completed
- Prostate Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Apr 24, 2015
Prostate Cancer Trial in Vancouver (Androgen suppression, radiotherapy, Androgen suppression, radiotherapy, iodine 125
Unknown status
- Prostate Cancer
- Androgen suppression, radiotherapy
- Androgen suppression, radiotherapy, iodine 125 brachytherapy
-
Vancouver, British Columbia, CanadaBC Cancer Agency
Mar 14, 2014
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Houston (leuprolide acetate, goserelin acetate, bicalutamide)
Terminated
- Adenocarcinoma of the Prostate
- Recurrent Prostate Cancer
- leuprolide acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 4, 2013